European Journal of Clinical Nutrition, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 24, 2024
Language: Английский
European Journal of Clinical Nutrition, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 24, 2024
Language: Английский
Pharmacological Research, Journal Year: 2024, Volume and Issue: 209, P. 107452 - 107452
Published: Oct. 8, 2024
Language: Английский
Citations
6Progress in Cardiovascular Diseases, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 1, 2024
Language: Английский
Citations
4Expert Review of Cardiovascular Therapy, Journal Year: 2025, Volume and Issue: unknown
Published: March 8, 2025
Introduction Invasive management of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) should be considered regardless age, but a key challenge is deciding which patients are most likely to benefit from an invasive approach in the older population. In addition assessment clinical signs and symptoms, holistic geriatric syndromes such as frailty, multimorbidity cognitive impairment increasing importance. Recent trials have validated roles physiological intracoronary imaging guide revascularisation.
Language: Английский
Citations
0Expert Opinion on Drug Metabolism & Toxicology, Journal Year: 2025, Volume and Issue: unknown
Published: April 10, 2025
Statins have significantly reduced mortality from cardiovascular diseases by lowering serum cholesterol levels. Beyond their lipid-lowering effects, statins improve vascular function, reduce inflammation, decrease reactive oxygen species (ROS) formation, and stabilize atherosclerotic plaques. However, the mechanisms underlying these pleiotropic effects remain unclear. This narrative review summarizes discusses epigenetic that may explain part of statins. approach allows for a reevaluation statin use beyond its cholesterol-lowering benefits. A structured search was conducted in PubMed Scopus databases using specific terms, including articles published up to August 2024. The statins, those mediated isoprenoid pathway, partially clinical By inhibiting histone deacetylases (HDACs, "erasers") DNA methyltransferases (DNMTs, "writers"), promote increased acetylation methylation at gene promoter regions. These modifications enhance chromatin accessibility, facilitating transcription protecting system. Further investigation into could support repositioning broader therapeutic applications. extend role managing hypercholesterolemia, potentially becoming first-line treatment preventing disease-related mortality.
Language: Английский
Citations
0Cell Biochemistry and Biophysics, Journal Year: 2025, Volume and Issue: unknown
Published: April 18, 2025
Language: Английский
Citations
0Life Sciences, Journal Year: 2024, Volume and Issue: 357, P. 123063 - 123063
Published: Sept. 17, 2024
Language: Английский
Citations
1European Journal of Clinical Nutrition, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 24, 2024
Language: Английский
Citations
0